MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
291.14%
Quick Ratio
291.14%
Cash Ratio
279.63%
Debt to Asset Ratio
32.55%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Property and equipment, net
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
21,987
46,450
65,711
77,596
Prepaid expenses and other current assets
905
2,284
2,462
2,843
Total current assets
22,892
48,734
68,173
80,439
Property and equipment, net
1,263
4,290
5,088
5,490
Restricted cash and cash equivalents
0
0
898
895
Operating lease right of use asset
0
4,998
5,422
5,620
Other assets
0
0
46
122
Total assets
24,155
58,022
79,627
92,566
Accounts payable
1,939
3,569
1,078
2,774
Accrued expenses and other current liabilities
5,924
4,515
9,021
8,543
Operating lease liability, current
0
1,604
1,504
1,454
Note payable, net of discount and issuance costs
0
28,831
6,000
2,400
Total current liabilities
7,863
38,519
17,603
15,171
Operating lease liability, net of current portion
0
7,216
8,140
8,587
Note payable, net of discount, issuance costs, and current portion
-
-
21,656
24,705
Derivative liability
0
85
2,614
2,639
Total liabilities
7,863
45,820
50,013
51,102
Common stock, 0.0001 par value, 200,000,000 shares authorized as of june30, 2026 and december31, 2025 48,599,066 and 48,596,817 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
5
5
5
5
Additional paid-in capital
501,559
501,139
496,638
492,118
Accumulated deficit
-485,272
-488,942
-467,029
-450,659
Total stockholders equity
16,292
12,202
29,614
41,464
Total liabilities and stockholders equity
24,155
58,022
79,627
92,566
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$21,987K (-71.66%↓ Y/Y)Prepaid expenses andother current assets$905K (-68.17%↓ Y/Y)Total current assets$22,892K (-71.54%↓ Y/Y)Property and equipment,net$1,263K (-76.99%↓ Y/Y)Total assets$24,155K (-73.91%↓ Y/Y)Total liabilities andstockholders equity$24,155K (-73.91%↓ Y/Y)Total stockholdersequity$16,292K (-60.71%↓ Y/Y)Total liabilities$7,863K (-84.61%↓ Y/Y)Accumulated deficit-$485,272K (-7.68%↓ Y/Y)Additional paid-in capital$501,559K (1.92%↑ Y/Y)Total currentliabilities$7,863K (-48.17%↓ Y/Y)Common stock, 0.0001par value,...$5K (0.00%↑ Y/Y)Accrued expenses andother current...$5,924K (-30.66%↓ Y/Y)Accounts payable$1,939K (-30.10%↓ Y/Y)

Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics, Inc. (HOWL)